Get started
AlenCiken

Achieving Highest Complete Remission Rate of Any Lupus study

Education
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)  
AlenCiken  
NASDAQ:AUPH   Aurinia Pharmaceuticals Inc
Trend Analysis Harmonic Patterns Chart Patterns
1
0
trendanalysis harmonicpatterns chartpattern
- Low dose voclosporin achieves CR rate of 49.4% at 48 weeks (p<.001)

- AURORA Phase III trial with low dose voclosporin on track to commence in Q2 2017

ir.auriniapharma.com...s-releases/detail/73

seekingalpha.com/art...even-better-expected

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.